1. Home
  2. XERS
  3. XERS News

Latest Xeris Biopharma Holdings Inc. (XERS) News on May 10, 2025

Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...
XERS

GuruFocus.com

20 hours ago

Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...

Xeris Biopharma (XERS) Reports Q1 Loss, Tops Revenue Estimates
XERS

Zacks

2 days ago

Xeris Biopharma (XERS) Reports Q1 Loss, Tops Revenue Estimates

XERS

Associated Press Finance

2 days ago

Xeris Biopharma: Q1 Earnings Snapshot

Xeris Biopharma Reports Record First Quarter 2025 Financial Results
XERS

Business Wire

2 days ago

Xeris Biopharma Reports Record First Quarter 2025 Financial Results

Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
XERS

Business Wire

9 days ago

Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit
XERS

Simply Wall St.

14 days ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit

Is Xeris Biopharma Holdings Inc. (XERS) the Best Multibagger Penny Stock to Buy According to Billionaires?
XERS

Insider Monkey

17 days ago

Is Xeris Biopharma Holdings Inc. (XERS) the Best Multibagger Penny Stock to Buy According to Billionaires?

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
XERS

GlobeNewswire

23 days ago

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

Xeris Announces Changes to Its Board of Directors
XERS

Business Wire

a month ago

Xeris Announces Changes to Its Board of Directors

Is Xeris Biopharma Holdings (XERS) The Hot Biotech Stock Under $5?
XERS

Insider Monkey

a month ago

Is Xeris Biopharma Holdings (XERS) The Hot Biotech Stock Under $5?

Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength?
XERS

Zacks

2 months ago

Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength?

Xeris Biopharma Holdings (XERS): Among the Best Stocks to Invest in for a Stock Market Game
XERS

Insider Monkey

2 months ago

Xeris Biopharma Holdings (XERS): Among the Best Stocks to Invest in for a Stock Market Game

Calculating The Fair Value Of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
XERS

Simply Wall St.

2 months ago

Calculating The Fair Value Of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)

XERS

MT Newswires

2 months ago

Xeris Biopharma Says US FDA Approves Gvoke VialDx for Diagnostic Use

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid
XERS

Business Wire

2 months ago

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

Xeris Biopharma Holdings Inc (XERS) Q4 2024 Earnings Call Highlights: Surpassing Revenue ...
XERS

GuruFocus.com

2 months ago

Xeris Biopharma Holdings Inc (XERS) Q4 2024 Earnings Call Highlights: Surpassing Revenue ...

Here's What Key Metrics Tell Us About Xeris Biopharma (XERS) Q4 Earnings
XERS

Zacks

2 months ago

Here's What Key Metrics Tell Us About Xeris Biopharma (XERS) Q4 Earnings

Xeris Biopharma (XERS) Reports Q4 Loss, Misses Revenue Estimates
XERS

Zacks

2 months ago

Xeris Biopharma (XERS) Reports Q4 Loss, Misses Revenue Estimates

XERS

Associated Press Finance

2 months ago

Xeris Biopharma: Q4 Earnings Snapshot

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance
XERS

Business Wire

2 months ago

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

Verrica Pharmaceuticals Inc. (VRCA) Expected to Beat Earnings Estimates: Should You Buy?
XERS

Zacks

2 months ago

Verrica Pharmaceuticals Inc. (VRCA) Expected to Beat Earnings Estimates: Should You Buy?

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025
XERS

Business Wire

2 months ago

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

Xeris Biopharma (XERS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
XERS

Zacks

2 months ago

Xeris Biopharma (XERS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer
XERS

Business Wire

3 months ago

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 50% stake, while 45% is held by institutions
XERS

Simply Wall St.

3 months ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 50% stake, while 45% is held by institutions

Xeris to Participate in Upcoming Investor Conferences
XERS

Business Wire

3 months ago

Xeris to Participate in Upcoming Investor Conferences

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness
XERS

PR Newswire

4 months ago

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

Xeris Biopharma raises FY24 revenue view to $203M from $198M-$202M
XERS

TipRanks

4 months ago

Xeris Biopharma raises FY24 revenue view to $203M from $198M-$202M

XERS

MT Newswires

4 months ago

Xeris Biopharma Lifts 2024 Revenue Guidance

Xeris Expects to Exceed Full-Year 2024 Financial Guidance
XERS

Business Wire

4 months ago

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
XERS

Business Wire

4 months ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference
XERS

Business Wire

5 months ago

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long
XERS

Simply Wall St.

6 months ago

Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long

XERS

MT Newswires

6 months ago

Piper Sandler Downgrades Xeris Biopharma to Neutral From Overweight, $3 Price Target

Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
XERS

GuruFocus.com

6 months ago

Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

Xeris Biopharma (XERS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
XERS

Zacks

6 months ago

Xeris Biopharma (XERS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Xeris Biopharma (XERS) Reports Q3 Loss, Tops Revenue Estimates
XERS

Zacks

6 months ago

Xeris Biopharma (XERS) Reports Q3 Loss, Tops Revenue Estimates

XERS

Associated Press Finance

6 months ago

Xeris Biopharma: Q3 Earnings Snapshot

Xeris Biopharma Reports Third Quarter 2024 Financial Results
XERS

Business Wire

6 months ago

Xeris Biopharma Reports Third Quarter 2024 Financial Results

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024
XERS

Business Wire

6 months ago

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

Several Insiders Invested In Xeris Biopharma Holdings Flagging Positive News
XERS

Simply Wall St.

7 months ago

Several Insiders Invested In Xeris Biopharma Holdings Flagging Positive News

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
XERS

Business Wire

7 months ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Zevra Therapeutics (ZVRA) Moves 9.1% Higher: Will This Strength Last?
XERS

Zacks

7 months ago

Zevra Therapeutics (ZVRA) Moves 9.1% Higher: Will This Strength Last?

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) most popular amongst individual investors who own 53% of the shares, institutions hold 43%
XERS

Simply Wall St.

8 months ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) most popular amongst individual investors who own 53% of the shares, institutions hold 43%

Xeris to Participate in Upcoming Investor Conferences
XERS

Business Wire

9 months ago

Xeris to Participate in Upcoming Investor Conferences

Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates
XERS

Zacks

9 months ago

Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates

XERS

Associated Press Finance

9 months ago

Xeris Biopharma: Q2 Earnings Snapshot

Xeris Biopharma Reports Second Quarter 2024 Financial Results
XERS

Business Wire

9 months ago

Xeris Biopharma Reports Second Quarter 2024 Financial Results

Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline
XERS

Zacks

9 months ago

Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline

Will Xeris Biopharma (XERS) Report Negative Earnings Next Week? What You Should Know
XERS

Zacks

9 months ago

Will Xeris Biopharma (XERS) Report Negative Earnings Next Week? What You Should Know

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024
XERS

Business Wire

9 months ago

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?
XERS

Zacks

10 months ago

Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?

XERS

MT Newswires

10 months ago

Xeris Biopharma Appoints John Shannon as CEO

Xeris Biopharma Announces CEO Succession Plan
XERS

Business Wire

10 months ago

Xeris Biopharma Announces CEO Succession Plan

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
XERS

Business Wire

10 months ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit
XERS

Simply Wall St.

a year ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024
XERS

Business Wire

a year ago

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024

XERS

MT Newswires

a year ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

XERS

MT Newswires

a year ago

Xeris Biopharma Says Potential Levothyroxine Injection Preferred Over Oral Formulation; Shares Rise

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)
XERS

Business Wire

a year ago

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

Xeris to Participate in the Jefferies Global Healthcare Conference
XERS

Business Wire

a year ago

Xeris to Participate in the Jefferies Global Healthcare Conference

Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges
XERS

GuruFocus.com

a year ago

Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
XERS

Insider Monkey

a year ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations
XERS

Simply Wall St.

a year ago

Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations

XERS

Thomson Reuters StreetEvents

a year ago

Q1 2024 Xeris Biopharma Holdings Inc Earnings Call

Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates
XERS

Zacks

a year ago

Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates

XERS

Associated Press Finance

a year ago

Xeris Biopharma: Q1 Earnings Snapshot

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
XERS

Business Wire

a year ago

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events

XERS

MT Newswires

a year ago

Xeris Biopharma Collaborating With Beta Bionics for Development, Commercialization of Glucagon Product

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
XERS

ACCESSWIRE

a year ago

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics

Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock
XERS

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
XERS

Business Wire

a year ago

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
XERS

Zacks

a year ago

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions
XERS

Simply Wall St.

a year ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
XERS

Business Wire

a year ago

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
XERS

Business Wire

a year ago

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results
XERS

Simply Wall St.

a year ago

Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results

Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023
XERS

GuruFocus.com

a year ago

Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
XERS

Insider Monkey

a year ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript

XERS

Thomson Reuters StreetEvents

a year ago

Q4 2023 Xeris Biopharma Holdings Inc Earnings Call

Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
XERS

Zacks

a year ago

Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates

XERS

Associated Press Finance

a year ago

Xeris Biopharma: Q4 Earnings Snapshot

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
XERS

Business Wire

a year ago

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
XERS

Business Wire

a year ago

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

Why Xeris (XERS) Might Surprise This Earnings Season
XERS

Zacks

a year ago

Why Xeris (XERS) Might Surprise This Earnings Season

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
XERS

Business Wire

a year ago

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference
XERS

Business Wire

a year ago

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

PIMCO Closed-End Funds Declare Monthly Common Share Distributions
XERS

GlobeNewswire

a year ago

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Ahead of Groundhog Day, LendingTree Introduces Spring: A Fresh New App Where Smart Money Habits Take Root
XERS

PR Newswire

a year ago

Ahead of Groundhog Day, LendingTree Introduces Spring: A Fresh New App Where Smart Money Habits Take Root

Logility Advances Supply Chain Supplier Management Capabilities for Apparel and Soft Goods Companies
XERS

Business Wire

a year ago

Logility Advances Supply Chain Supplier Management Capabilities for Apparel and Soft Goods Companies

XERS

Investing.com

a year ago

Dollar edges higher ahead of Fed meeting, payrolls

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?
XERS

Zacks

a year ago

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?

Udemy to Announce Fourth Quarter and Full Year 2023 Results on February 14
XERS

GlobeNewswire

a year ago

Udemy to Announce Fourth Quarter and Full Year 2023 Results on February 14

XERS

Thomson Reuters StreetEvents

a year ago

Q4 2023 CrossFirst Bankshares Inc Earnings Call

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
XERS

Zacks

a year ago

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Matterport to Announce Fourth Quarter & Full Year 2023 Results on February 20, 2024
XERS

GlobeNewswire

a year ago

Matterport to Announce Fourth Quarter & Full Year 2023 Results on February 20, 2024

Compared to Estimates, CrossFirst (CFB) Q4 Earnings: A Look at Key Metrics
XERS

Zacks

a year ago

Compared to Estimates, CrossFirst (CFB) Q4 Earnings: A Look at Key Metrics

Anterix (ATEX) Loses -13.76% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
XERS

Zacks

a year ago

Anterix (ATEX) Loses -13.76% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza
XERS

Zacks

a year ago

Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza

The RMR Group Announces Quarterly Dividend on Common Shares
XERS

Business Wire

a year ago

The RMR Group Announces Quarterly Dividend on Common Shares

Share on Social Networks: